chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8am EE noted fanning herself, states she feels warm but just got off nights.  Ice pack given for neck. 8:03 C/O itchiness on chest, heart racing, neck and chest with mild redness.  No SOB or tightness in throat.  RN notified and came to assist.  Left arm vaccine injection site asymptomatic.  EE refused Benadryl. BP 143/105, P81 PO 100% 8:08am Continue to feel itchy on chest and neck BP 153/91 P-76 PO 100% continue to refuse Benadryl 8:10am Benadryl 25mg po given, juice and crackers 8:14am BP 151/86 P-65 PO 100% changed to reclining chair to elevate feet, no tightness in chest or throat. 8:20am EE c/o left arm tingling/numbness down to fingers, denies CP no SOB, states it is like she hit her funny bone. BP 151/86 P75 PO 100% RN notified and evaluated her. 8:35am EE feeling cool. BP 131/88 P-69 PO 100%.  EE states she feels like the Benadryl is working , redness less on neck and states she feels more relaxed, continues to have left arm numbness. 9am EE states she feels better, a little itchy on neck but no redness.  BP 123/87 P 73 numbness decreased and almost gone.  OK to go home per RN and instructed to take Benadryl when she gets home and to call the Covid vaccine hotline if needed or 911 if any resp. distress or CP.  Requested her to text or email RN when she arrives home. EE states she understands.  RN states she heard from EE and she is home.  RN
Information has been received from a consumer referring to her child of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 11-AUG-1997, the patient was vaccinated with the first dose of an unspecified hepatitis vaccine (lot# reported as 1555D, expiration date unknown, manufacturer unknown, product was possibly RECOMBIVAX HB (dose and route unknown) at one year of age. On an unknown date, the patient experienced an unspecified bad reaction. The patient was found to be autistic at 2 years of age (in approximately 1998). The outcome of the events was unknown. The causal relationship between the events and unspecified hepatitis vaccine was unknown. Upon internal review, autistic was considered to be medically significant. Additional information is not expected as we have no consent to contact the physician.
Jansen COVID-19 Vaccine EUA  Next morning  - 101 Fever - Body aches - Eye pain  Four days later - significant lower eyelid swelling
The patient woke up on Thursday night with a red rash, now raised or blistered, over the entire body. On 12/21/00, follow up phone call with the patient. Contacted the doctor per PHN recommendation on 12/01/00. was instructed to take OTC Benadryl which resolved the rash. Encourage follow up with the doctor before taking another Flu shot. Elevated symptoms next time.
I received the shot on Saturday, March 6th. Flu-like symptoms developed 12 hours after (aches, chills, extreme fatigue) and lasted about 12 hours -- pain in left arm lasted a full five days. On Thursday March 11th I started to develop a cold sore on my chin which was followed by malaise and swollen glands. I treated it with Zovirax. On Wednesday March 17th I developed what looked to be a pimple in the middle of my left eyelid. There was a small white/ fluid filled head about the size of a pin head. Over the next three days, three more fluid-like blisters the size of a pin-head began to develop on upper eyelid. By Tuesday March 23rd, I had over half a dozen fluid filled blisters that were painful and began to crust. The blisters extended from upper eyelid to below the brow (only on left side of face). On Tuesday March 23rd I went to the eye doctor. The eye doctor had asked if I ever had shingles (I have had the chicken pox vaccine, but never had chicken pox nor shingles). I have had HSV-1 since childhood and get the yearly cold-sore when stressed or immunity is low, but I never have had cold sores appear anywhere else other than lip/chin area. The doctor had suspected the eye blisters were a form of herpes and prescribed me 14 days of Valacyclovir. The blisters only affected the skin-- not the cornea or inside eye. Within a day and a half of the antivirals medication, the blisters were fully crusted over and started to clear up.
improperly stored vaccine administered; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On an unknown date, the patient was vaccinated with one dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (Thimerosal Free) lot # S007075, expiration date 06-SEP-2020 (injection site and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 32.5 degrees Fahrenheit for 8 hours. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. The outcome of event was unknown.
Diarrhea; a slight headache; Really tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 11Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious) with onset 12Mar2021, outcome "unknown", described as "Diarrhea"; HEADACHE (non-serious) with onset 11Mar2021, outcome "unknown", described as "a slight headache"; FATIGUE (non-serious) with onset 11Mar2021, outcome "recovering", described as "Really tired".  Additional information: Caller on the line calling about the Pfizer COVID 19 shot. After getting the first shot he had to run errands and came back home. Early that evening she started to get a slight headache that she no longer has. She also felt tired, but now she was not as tired. Today, (12Mar2021) she started to have diarrhea. She also wanted to know if she could take Imodium. She also stated, the number on the paper they were provided was very misleading. Stated on the paper it indicates if have a question or experience "this" to call this number, and she called that number and ends up getting us. She stated she was very upset and was going to complain.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The physician ordered a moderna booster 6m-5y but was given the moderna booster 6-11y.
9-13-2011 Appearance of "rash" - on face and chest treated with oral steroids and antihistamine. 9-25-2011 Rash still present. Treated with more prednisone. Nov - Dec 2011 - Treated with topicals; Jan 2012 more topicals. June 2012 muscle contractures, rash, fatigue, muscle weakness. July 2012 - Dermatomyositis - prednisone, SOLUMEDROL, IVIG, CELLCEPT.
The pt developed a 4-5 cm area of erythema and slight edema 5 minutes post vax. No other symptoms. 30 minutes post vax, symptoms resolving.
Event happened at home, patient was taken to ER where he was treated. Health Dept notified. Upper extremity edema right greater than left, facial edema right greater than left, slight heel edema right greater than left, Tingling sensation in tongue  Treatment with IV Benadryl, Dexamethasone, and Pepcid. Discharged with new RX Epi pen, steroids, and Pepcid
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Chills-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: we called 911 for pt after he had all these symptoms.he laid down on the floor and we elevated his legs.it took hom up to 25 mon to feel bettwe and go home.he did not go urgent care after that .he went home.
40 minutes post vaccine, client still present during  post vaccine respite, cl described she began feeling generalized warmth and itching, denied feeling any oral or respiratory symptoms, NP observed cl was unable to stop scratching her arms, thighs, chest, and anterior chest wall was quite erythematous, lungs CTA, vital signs stable, though hypertensive in her reported normal range, 50 mg IM Benadryl administered, symptoms improved significantly, cl was monitored an additional 20 minutes after that, cl went to work where she works with a NP who "said she did fine the rest of the day."
flu; Initial information received on 23-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves a patient with unknown demographics who had flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient had flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken  was not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
Upon review of file, I found out his reaction to the 2nd shot of Hep B was not reported so I am reporting it now. Within hours after the shot he had a temp of 101-103 degrees, "head pain", "neck pain", no appetite, dry wheezing cough with no congestion. He was pale and lethargic. He was like this for 3 days. Motrin did help temp get down to 101 degrees. This time he did recover.
Patient came in with a warm red patch on her left arm 3 inches below the injection site. She said that it did not cause her pain and did not itch. Per our treatment protocol, patient was advised to use ice and ibuprofen to control any pain/swelling.
pt recv vax reddened areas noted @ both deltoid inj site, immed p/shots given;no signs & sx of distress, vital signs as follows BP 94/62, T97l.3, P84, R20;child observed for 30mins w/no further problems noted;
A spontaneous report has been received from a physician. The report concerns a patient of unknown gender (age not provided) of Unknown ethnic origin. No medical history was reported. The following demography was reported for the patient's parent: Sex: Unknown No concomitant products were reported. The patient started treatment with FLUMIST QUADRIVALENT (batch number(s) Not reported), nasal, on an unknown date for flu vaccine. On 15-FEB-2019, the patient experienced nasal irritation  and physician reporting that when giving flumist in the past patients have experienced myalgia.   Treatment with FLUMIST QUADRIVALENT was not changed. The outcome of the event(s) of nasal irritation and physician reporting that when giving flumist in the past patients have experienced myalgia was unknown.  The events were considered non-serious.
PATIENT'S MOTHER REPORTS SHE WAS GIVEN THE VACCINATION ON 10-25-17 AND WITHIN 24 HOURS, SHE COULD NOT WALK AND HAD TO BE TAKEN TO THE EMERGENCY ROOM.
We had a routine covid-19 test at work on 2/2/2022. I had a sore throat, coughing, fatigue, headache, and congestion. My rapid test came back negative and PCR test came back positive on 2/3/2022. The congestion, coughing, and headaches lasted for 4-5 days. The fatigue lasted for a couple weeks. I treated my symptoms with cough medicine and rest. I recovered from covid-19 on 2/6/2022.
This report describes the occurrence of a probable toxic epidermal necrolysis / Stevens Johnson Syndrome in a 8.7 year old boy receiving Hepatitis B vaccine. On an unknown date, a dose of Hepatitis B vaccine was given. On the same day, after vaccination, the face of the child became red and "blotchy." He was given Acetaminophen (Paracetamol) and went to bed with a "runny nose." The next day, his face looked as if it had been sunburned and the rash spread to his abdomen and groin. The child was hospitalized with epidermal detachment, mucous membrane involvement and joint stiffness. The case was diagnosed by a dermatologist. The vaccination course has been discontinued. This case was classified by the authors as a probable Stevens-Johnson syndrome / toxic epidermal necrolysis. The authors made the following comments: "For the one definite and five probable cases, 2 features support a causal relationship between vaccination and SJS/TEN. First the patients did not have evidence of an acute illness and were not taking other medications at the time of the vaccination, reducing the chance the rash was caused by another etiology. Second the timing of the onset of symptoms and the diagnosis of SJS/TEN after vaccination is consistent with the published literature on SJS and TEN after medication and infection." Nevertheless, they mentioned that a causal link between SJS/TEN and vaccination could not be established by this study for different reasons.
NY Urologist treated a 60 year old male who was positive for HPV type 6 and 11 genital warts with the GARDASIL 9 vaccine; the patient had no additional transmission or progression, as well as reported remission of HPV; This spontaneous report was received from a physician assistant and refers to a 60-year-old male patient. There was no information about the patients, medical history, drug reactions or allergies and concomitant therapies provided. His concurrent conditions included Human Papilloma virus (HPV) 6 and 11 (unspecified) and genital warts.  On an unknown date, the patient current condition of HPV was treated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, dose, route of administration, anatomical location, frequency, lot number and expiration date were not reported) (Off label use in unapproved indication).  The reporter stated that, according to the article he read, the patient had no additional transmission or progression, as well as reported remission of HPV (drug effective for unapproved indication).
After sitting and waiting the 15 minutes, I left and as I was walking, I had the strongest taste of metal in my mouth.  It lasted for about a minute, then slowly went away.; This is a spontaneous report from a contactable consumer. A 54-year-old female patient received first dose of bnt162b2 (BNT162B2; lot EK5730), via an unspecified route of administration on 16Dec2020, at 11:00 AM at single dose (right arm) for immunization. Medical history included asthma, hypertension (HTN), and allergies penicillin (PCN), medications, food or other products, many seasonal items, grass, trees, molds, dust mites, carrots, apples, celery, and walnuts. The patient did not received any other vaccines within four weeks prior to Covid vaccine. Concomitant medications were not reported. Patient reported that she had other medications received within 2 weeks of vaccination.  On 16Dec2020, at 11:15 AM, after sitting and waiting the 15 minutes, the patient left and as she was walking, she had the strongest taste of metal in her mouth. It lasted for about a minute, then slowly went away. There was no treatment for the event. The patient did not have Covid prior the vaccination and was not Covid tested post vaccination. Outcome of event was recovered on 16Dec2020.
PATIENT EXPERIENCE SIGNIFICANT SWELLING AND REDNESS AT INJECTION SITE. SWELLING EXTENDED THE CIRCUMFERENCE OF THE ARM FROM SHOULDER TO BICEP.  ALSO EXPERIENCED WELTS NEAR THE INJECTION SITE BUT NOT COVERING THE ENTIRE ARM.  PATIENT DID NOT REPORT SIGNIFICANT PAIN OR DISCOMFORT.  DID NOT SEEK TREATMENT. SYMPTOMS RESOLVED WITHIN 48 HOURS.
Immediate tingling to face, then on 12/23 migraines and smell adversions, 12/24 chills body aches and skin burned, 12/25 no taste or smell with chills body aches diarrhea skin burned and brain fog, 12/26 positive rapid covid test and symptoms continue
after second dose of vaccine, patient had Internal jugular (IJ) vein thromboembolism, acute, right; Mucositis; Sore throat. Admitted for Chemotherapy-induced neutropenia; Infection of venous access port. Discharged after one day.
Pt. states that on Friday 12/22/2017 he became ill, vomiting, chills, aches, had to have someone drive him home from work. Injection site was warm and hot. Also notes that it was sore with a raised warm area and a "hard lump" was noted in arm.
MY SLEEPING PATTERN IS BACKWARDS, COUGHING, VERY TIRED, DEPRESSED, SCARED OF PEOPLE, MAKES ME ISOLATE NOW I HAD NO SENSE OF TIMING ON DAY AND NIGHT I DONT EVEN CARE ANY MORE IM TIRED
About 30-45 minutes after my shot, I noticed my speech was slurring. I was very tired and also saying words that did not apply to what I was talking about. The slurring was not constant.
Reaction to small pox lot number VV04003A. Pt. Developed rash covering entire body 6 days after vaccination. Pox fully formed then reaction occurred. Rash is still ongoing pt on day 2 receiving care.
Covid arm. Swollen, itchy, hot, red rash at injection site. About 2-3? in diameter. Started small about the size of a nickel. 24 hrs later it?s 2-3?.
Swelling and redness, soreness at injection site. Sx began the day after vaccine, worse by 48 hours. Then had 8x6 cm area of swelling, erythema, induration and tenderness, with central, tender raised whelp of 2x2 cm. Treated with cool compresses and Zyrtec 10mg for itching.
rash, itching appeared 22APR99 runny nose;rx DPH, baking soda baths, calamine lotion;rash vesicular on wide red base;
Immediately after receiving the vaccine, client started c/o severe pain in her arm and lightheadenness and shallow breathing. vital signs monitored. no meds administered. Son at her side. This information was obtained from her son. He says she has bad arthritis and the shot hurt her and she almost passed out. She has had no other problems since and didn't have any with the first dose.
Vaccine expired on 04-Apr-2022 and administered on 22-Apr-2022, doses were administered after the expiration date/Administered after 30-day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were administered after the expiration date/Administered after 30-day use by date) and PRODUCT STORAGE ERROR (Vaccine expired on 04-Apr-2022 and administered on 22-Apr-2022.) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were administered after the expiration date/Administered after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 04-Apr-2022 and administered on 22-Apr-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were administered after the expiration date/Administered after 30-day use by date) and PRODUCT STORAGE ERROR (Vaccine expired on 04-Apr-2022 and administered on 22-Apr-2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The reporter stated that vaccine their office administered were expired at the time of administration.  The vials were thawed on same day of administration and the vial didn't undergo any temperature excursions.  On 22-Apr-2022, the patient received first booster dose of expired Moderna vaccine.  The patient had no known reactions at office. The patient's weight was reported as 99 with unknown units.  No treatment information was provided.
24 hrs after admin had 6x6cm red indurated area. Local rxn (R) arm site of MENVEO admin.
This spontaneous prospective pregnancy report as received from a nurse practitioner refers to a female patient of unknown age. On 14-MAY-2013 the patient was vaccinated with the first dose of GARDASIL (route not reported) when she was 37 and a half wekks pregnant. The patient became pregnant with LMP of 17-AUG-2012 and EDD of 24-MAY-2013. The pregnancy outcome was outcome pending. No adverse effect was reported. Additional information has been requested.
pain lt elbow-radiating to wrist down back & lt leg, felt drowsy, low grade temp, nausea;
GI Symptoms; EGD Mild Inflammation; 70 year old woman with these symptoms/ intermittent nausea, abdominal bloating, epigastric pain, indigestion, and chest pain; 70 year old woman with these symptoms/ intermittent nausea, abdominal bloating, epigastric pain, indigestion, and chest pain; 70 year old woman with these symptoms/ intermittent nausea, abdominal bloating, epigastric pain, indigestion, and chest pain; 70 year old woman with these symptoms/ intermittent nausea, abdominal bloating, epigastric pain, indigestion, and chest pain; 70 year old woman with these symptoms/ intermittent nausea, abdominal bloating, epigastric pain, indigestion, and chest pain; Menopause; This is a spontaneous report from a contactable other HCP. This is a report 4 of 5.   A 70-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot number: Unknown, Expiration date: unknown) via unspecified route of administration on an unspecified date (at the age 70-year-old) as 2ND DOSE, SINGLE for COVID-19 immunisation. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection; Lot number: Unknown, Expiration date: unknown) via unspecified route of administration on an unspecified date as first dose single for COVID-19 immunisation. Patient had no medical history. concomitant medications were not reported. On an unspecified date, patient experienced Gastrointestinal (GI) Symptoms, Esophago-Gastro Duodenoscopy (EGD) mild Inflammation, intermittent nausea, abdominal bloating, epigastric pain, indigestion, chest pain and menopause. Reporter wants to know what symptoms are being seen in the area of reflux and gastritis status post vaccine, 2-3 months out. Reporter states she started peri menopause and it through her into menopause and tested with waves of intermittent nausea, abdominal bloating, epigastric pain, indigestion, and chest pain. She was put on a PPI and she tried to do 20mg a day, but she has to do 20mg twice a day. Reporter states she thought maybe she developed a gluten sensitivity and that reacts to wheat protein, so she tried to cut that out. Reporter states she has reached out to her colleagues, and they reported a 70-year-old woman with these symptoms. The patient underwent lab test and procedure include Esophago-Gastro Duodenoscopy (EGD) endoscopy with mild inflammation on an unspecified date. Outcome of the events were unknown.  Follow-up attempts are needed. Further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021623869 same reporter/drug/similar events, different patient;US-PFIZER INC-2021623328 same reporter/similar event, different patient